Uncoupling protein 2 (UCP2) is a mitochondrial modulator which protects against endothelial dysfunction. However, the role which UCP2 plays in endothelial apoptosis and its association with DR was unclear. In the present study, we investigated whether UCP2 functioned as an inhibitor of DR in endothelial cells. Firstly, we noted that in UCP2-knockout mice retinal cell death and damage in vivo was similar to that of db/db diabetic mice. Additionally, UCP2 knockdown induced caspase-3 activation and exaggerated high glucose (HG)-induced apoptosis of human umbilical vein endothelial cells (HUVECs). Conversely, adenovirus-mediated UCP2 overexpression inhibited the apoptosis of HUVECs and HG-induced caspase-3 activation. Furthermore, HG treatment resulted in the opening of the permeability transition pore (PTP) and liberation of cytochrome c from mitochondria to the cytosol in HUVECs. Notably, UCP2 overexpression inhibited these processes. Furthermore, adenovirus-mediated UCP2 overexpression led to a significant increase in intracellular nitric oxide (NO) levels and a decrease in reactive oxygen species (ROS) generation in HUVECs. Collectively, these data suggest that UCP2 plays an anti-apoptotic role in endothelial cells. Thus, we suggest that approaches which augment UCP2 expression in vascular endothelial cells aid in preventing the early stage development and progression of DR.
Introduction
Diabetic retinopathy (DR) is the most common complication of diabetes and the principal cause of blindness in working-age individuals (1) . The early stages of DR are characterized by microvascular cell damage (2) . Microvascular cell damage is associated with thickening of the capillary endothelial basement membrane (BM) and pericyte apoptosis induced by hyperglycemia (3) . In cases of DR, apoptotic cells have been found in all retinal layers, including retinal endothelial cells (4) .
Previous investigations into the molecular mechanisms that cause DR have largely focused on vascular endothelial growth factor (VEGF) (5, 6) . This may be attributed partly to the fact that the prominent clinical characteristics of DR have led to the general inference that DR is entirely of a microvascular nature. Although significant effort has been invested in elucidating the mechanisms that govern destructive preretinal neovascularization in DR (7), considerably less is known about the cellular processes that lead to increased retinal vascular apoptosis. Mitochondrial uncoupling protein 2 (UCP2) is a novel member of the mitochondrial anion carrier family, and displays 60% sequence identity with the well-known thermogenic UCP1 from brown adipose tissue (8) . Previous studies have suggested that UCP2 is involved in the control of mitochondrial membrane potential (9) and the generation of reactive oxygen species (ROS) (10) . Recently, a unifying hypothesis has emphasized the important role played by increased mitochondrial ROS production in complications of diabetes, including retinopathy (11) . Previously, we demonstrated that peroxisome proliferator-activated receptor γ (PPARγ)-mediated changes to UCP2 involve the mitochondrial-ROS pathway, which is associated with a decreased VEGF-to-pigment epithelium-derived factor (PEDF) ratio caused by the effect that angiotensin-converting enzyme inhibitor (ACEI) exerts on DR (12) . Moreover, we investigated the inhibition of high glucose-induced apoptosis by UCP2 in human umbilical vein endothelial cells (13) . However, the more detailed mechanism of UCP2 in vascular endothelial cell apoptosis in DR has not been explored to date, to the best of our knowledge.
In the present study, using both UCP2-knockout mice and HUVECs, we provide evidence that UCP2 plays an anti-apoptotic role. UCP2-knockout mice exhibited retinal cell death and damage in vivo, which was similar to db/db diabetic mice. Additionally, UCP2 knockdown exaggerated high glucose (HG)-induced apoptosis and caspase-3 activity in human umbilical vein endothelial cells (HUVECs). Furthermore, we demonstrated that adenovirus-mediated UCP2 overexpression exerted a protective effect on apoptosis, and investigated the opening of the permeability transition pore (PTP), cytochrome c release, ROS generation and nitric oxide (NO) production in HUVECs. Thus, inducing UCP2 expression may represent an alternative therapeutic strategy in the early stage of DR.
Materials and methods
Cell culture and adenovirus transfection. HUVECs were obtained from ScienCell Research Laboratories (San Diego, CA, USA). The cells were cultured in endothelial cell medium (ECM) (ScienCell Research Laboratories) with 5% (v/v) fetal bovine serum (FBS) at 37˚C in an atmosphere with 5% (v/v) CO 2 and 95% humidity. When they reached confluence, the cells were maintained in 1% (v/v) fetal calf serum and exposed to normal amounts of glucose (5.5 mmol/l) or high amounts of glucose (30 mmol/l) for 3-7 days, during which time the medium was changed every 2 days. When HUVECs reached approximately 50% confluence in fresh serum-free medium, they were transiently transduced with control adenovirus β-galactosidase (Ad-β-gal) or with adenovirus overexpressing UCP2 (Genechem, Shanghai, China) at multiplicities of infection (MOI) of 10. The cells were further cultured in ECM with 5% (v/v) FBS after infection for 4 h and then selected using 200 µm/ml puromycin (Thermo Fisher Scientific, Waltham, MA, USA). The stable overexpression lines were established when more than 95% of the transduced cells were found to strongly express green fluorescent protein (GFP) under a fluorescence microscope (BX51; Olympus, Tokyo, Japan).
Animals and sample preparation. All experiments in the present study comply with the requirements of the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. Eighteen-week-old male C57 mice weighing ~20 g and db/db diabetic mice weighing ~20 g were obtained from the Shanghai Laboratory Animal Center of Chinese Academy of Sciences (Jiuting, Shanghai, China). UCP2-deficient mice weighing ~20 g were obtained from the Shanghai Biomodel Organism Research Center (Jiuting, Shanghai, China). This study was approved by the Ethics Committee of Shanghai Jiao Tong University School of Medicine.
UCP2 siRNA transfection. Target sequences were aligned to the human genome database in a BLAST search to ensure that the chosen sequences were not highly homologous with those of other genes. Cells were seeded in 6-well plates and cultured in drugfree medium (ScienCell Research Laboratories, Carlsbad, CA, USA). When cells reached 90-95% confluence they were washed twice with phosphate-buffered saline (PBS) and grown in 2 ml ECM without antibiotics. Using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA), the indicated concentration (50 nM) of UCP2 siRNA oligo (Genechem) was transfected into HUVECs according to the manufacturer's instructions. Cells transfected with control siRNA served as a negative control. Forty-eight hours later, the expression levels of UCP2 were evaluated by western blot analysis. The cells transfected with siRNA were used for experiments 48 h after transfection.
Western blot analysis. Western blot analysis was performed, as previously described (14) . Briefly, the primary antibodies used to probe the membranes included anti-UCP2 (1: Assessment of the release of cytochrome c and subcellular localization of UCP2 protein expression. For the analysis of the release of cytochrome c from mitochondria into the cytosol, proteins in the cytosol and mitochondrial fractions were separated by SDS/PAGE. Bands of proteins were transferred onto a PVDF membrane (Millipore, Bedford, MA, USA). Cytochrome c was detected with an enhanced chemiluminescence western blot analysis system (Amersham, Buckinghamshire, UK) with monoclonal antibodies specific to cytochrome c (1:200, cat. no. 1896-1; Epitomics). The same method for western blot analyses was used on cytosolic and mitochondrial preparations using antibody against human UCP2 (1:500, cat. no. ab67241; Abcam) and subunit IV of cytochrome oxidase (1:500, cat. no. ab110272; Abcam).
Flow cytometric analysis.
For quantification of cellular viability, cells were double-stained with Annexin V and propidium iodide (PI) according to the manufacturer's instructions [Annexin V-fluorescein isothiocyanate (FITC) apoptosis detection kit (BD Biosciences, Franklin Lakes, NJ, USA)]. The proportion of apoptotic and necrotic cells was determined using FACSCalibur (Becton-Dickinson, San Jose, CA, USA). Annexin-V is a marker of apoptosis, and PI reflects the integrity of the cell membrane, thereby serving as a marker of necrosis.
Caspase-3 activity. Caspase-3 activity was determined using a caspase-3 colorimetric protease assay kit (Beyotime Institute of Biotechnology, Shanghai, China) following the manufacturer's instructions. Briefly, the kit uses spectrophotometry to detect the chromophore p-nitroaniline (pNA) after cleavage from the labeled substrate DEVD-pNA (DEVD is the sequence recognized by caspases). The free pNA was quantified using a spectrophotometer or a microtiter plate reader at 405 nm. The ratio of absorbance from a sample to that from a control allows for the determination of the fold increase of caspase-3 activity.
Assessment of mitochondrial permeability transition pore (mPTP) opening.
To determine the effect of UCP2 overexpression on mPTP opening, a previously validated cell model of mPTP opening was used (15) . A microplate spectrofluorometer (SPECTRAmax GEM-INI-XS; Molecular Devices, Sunnyvale, CA, USA) was used to study stimulation of the fluorophore, tetramethylrhodamine methyl ester (TMRM), which accumulates in mitochondria, and generation of ROS within mitochondria. Culture medium was removed and replaced with Krebs imaging buffer. Cells were then loaded with 3 mM TMRM for 15 min at 37˚C and washed with Krebs imaging buffer (Guidechem, Shanghai, China). The time taken to induce mitochondrial membrane depolarization is recorded as a measurement of mPTP opening. This was defined as the time taken to reach half the maximum TMRM fluorescence intensity. Twenty transfected cells were randomly selected for the induction and detection of mPTP opening from each treatment group, and this was repeated in four independent experiments, providing a total of 80 cells/treatment group. As a positive control and in order to confirm that mitochondrial membrane depolarization was indicative of mPTP opening, following TMRM loading, a group of cells were pretreated for 10 min with the mPTP inhibitor, cyclosporin A (CsA; 0.2 mM; Selleck Chemicals, Houston, TX, USA), as previously described (16) (17) (18) . The time taken to induce mPTP opening was recorded.
Measurement of intracellular ROS production and NO levels.
In the present study, HUVECs were incubated with 10 µmol/ml carboxydichlorodihydrofluorescein diacetate (DCFH2-DA; Molecular Probes, Inc., Eugene, USA) at 37˚C. After 15 min incubation, the increase in DCFH2 oxidation was measured using a FACSCalibur (Becton-Dickinson) (19, 20) . The NO level in HUVECs was measured in situ using DAF-FM diacetate (Sigma-Aldrich), as previously described (21) .
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay. Mice were sacrificed by cervical dislocation. Eyes were removed from four 8 week-old db/db mice, four age-matched UCP2-KO mice and four age-matched normal mice were used as control retinas. The eyes were immediately enucleated and the retina was separated. The retina from one of the eyes was frozen in liquid nitrogen and stored at -80˚C. TUNEL was performed on frozen sections using the DeadEnd™ TUNEL assay kit (Promega, Madison, WI, USA) and were counterstained with PI, according to the manufacturer's suggestions. Briefly, sections were hydrated with alcohol (100, 95 and 70%), and then fixed in 3.7% paraformaldehyde. After washing, the slides were incubated in a mixture of TdT, Mn
2+
, and TdT dNTP (Sangon Biotech, Shanghai, China) for 1 h at 37˚C. The reaction was stopped with TdT Stop Buffer (Trevigen, Gaithersburg, MD, USA) for 5 min. After washing with deionized water, the slides were incubated with streptavidin-FITC (diluted 1:200) solution for 20 min at room temperature. Slides were counterstained, mounted, covered with coverslips, and visualized by confocal microscopy (LSM 510; Carl Zeiss, Inc., Oberkochen, Germany). Apoptotic cells were identified as doubly labeled with TdT fluorescein and PI, and only the nuclei which were clearly labeled yellow were scored.
Transmission electron microscopy. Tissue processing, electron microscopy, morphometric measurements [retinal capillary basement membrane thickness (BMT)], and statistical analysis were performed as detailed in our previous study (12) . Eyes were removed from four 8 week-old db/db mice, four agematched UCP2-KO mice and four age-matched normal mice were used as control. Briefly, enucleated eyes were fixed in 2.5% (w/v) glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) containing 0.2% (v/v) tannic acid, washed in the same buffer, and post-fixed in 0.5% (v/v) osmium tetroxide. Tissue sections were block stained with uranyl acetate, lead stained, dehydrated through a graded series of ethanol, and embedded in Epon. One-micrometer-thick sections were examined with a JEM-1200EX transmission electron microscope (JEOL, Ltd., Akishima, Japan). Computer-assisted morphometric measurements (The Image Center of Beijing University of Aeronautics and Astronautics, Beijing, China) were performed on electron micrographs taken from 12 randomly selected capillaries of the outer plexiform layer from four different tissue blocks of the same retina. Only cross-sectioned capillaries were considered. A total of 96 capillaries were evaluated in each experimental group.
Statistical analysis. SPSS 17.0 was used to analyze the experimental data. All experimental data are represented as the means ± standard deviation (SD). One-way analysis of variance (ANOVA) followed by Student-Newman-Keuls test was used to compare the effect of treatment on the various parameters. Non-parametric data was analyzed using the Chi-square test or Fisher's exact method. A P-value <0.05 was considered to indicate a statistically significant difference.
Results

Retinal cell death and damage in mice.
Loss of cells in the ganglion cell layer was due to apoptosis, and this was reflected as an increase in TUNEL in the ganglion cell layer of both the UCP2-knockout mice and db/db mice. We performed TUNEL on retinal sections to measure cell death in the UCP2-knockout mice and db/db mice. Notably, we found that UCP2-knockout mice exhibited a DR-like phenotype, similar to db/db mice. Fig. 1A and C illustrate increased TUNEL in the ganglion cell layer of UCP2-knockout mice and db/db mice compared to their normal counterparts. Furthermore, compared to the non-diabetic mice, the BMT was significantly increased in the UCP2-knockout mice and db/db mice (P<0.01) (Fig. 1B and D) . However, there was no significant difference in BMT between UCP2-knockout mice and db/db mice. Therefore, these results demonstrate that knockdown of UCP2 is a critical factor for retinal cell death and damage.
Knockdown of UCP2 exaggerates HG-induced apoptosis and activated caspase-3 in HUVECs.
UCP2 siRNA effectively reduced endogenous levels of UCP2 protein compared to control siRNA ( Fig. 2A) . UCP2 siRNA increased caspase-3 expression to a significant extent, whereas control siRNA did not (Fig. 2B) . UCP2 siRNA exaggerated HG-induced apoptosis compared to control-siRNA infected cells (Fig. 2C and D ). These data demonstrate that endogenous UCP2 expression is important for preventing apoptosis in HUVECs.
Subcellular localization of UCP2 protein in UCP2-overexpressing HUVECs.
In the present study, HUVECs were infected with adenovirus carrying UCP2 cDNA in sense orientation at an MOI of 1, 5 and 10 pfu/cell for 24 h. Immunofluorescence micros-copy was then used in order to observe UCP2 eGFP expression in infected cells. At an MOI of 10 pfu/cell, UCP2 eGFP expression was detected in >95% of cultured cells (Fig. 3A) . UCP2 was overexpressed mainly within the mitochondria (Fig. 3B and C) .
UCP2 overexpression inhibits HG-induced apoptosis and caspase-3 activity in HUVECs.
HG increased HUVEC apoptosis by 4.1-fold; UCP2 overexpression reduced HG-induced apoptosis by 65% in HUVECs (Fig. 4A) . FACScan analysis revealed that UCP2 overexpression inhibited both HG-induced apoptosis and necrosis of HUVECs (Fig. 4A and B) . HG induced a significant increase in caspase-3 activity in HUVECs (Fig. 4C and D) . The HG-induced increase in caspase-3 activity was inhibited by transfection with Ad-UCP2. The generation of active caspase-3 from the proenzyme was enhanced in the presence of HG (Fig. 4C and D) . HG-induced cleavage of caspase-3 into active subunits was thus prevented in the presence of UCP2.
UCP2 overexpression delays mPTP opening and blocks cytochrome c release. UCP2 overexpression in HUVECs decreased the susceptibility of the cells to mPTP opening. UCP2 overexpression in HUVECs delayed the time of mPTP opening by 1.5±0.2-fold when compared to control values (P<0.01) (Fig. 5A ). In addition, treatment with HG resulted in the liberation of cytochrome c from mitochondria to the cytosol (Fig. 5B) . The liberation of cytochrome c by HG was blocked in cells overexpressing UCP2 (Fig. 5B) .
UCP2 overexpression suppresses intracellular ROS production and increases the intracellular NO levels in HUVECs.
Previous research has indicated that UCP2 is activated by ROS and attenuates excessive ROS production in the form of a negative feedback mechanism (22) (23) (24) . Thus, in the present study, the levels of ROS were determined in HUVECs. Incubation with HG significantly increased intracellular ROS generation. However, upon UCP2 overexpression, we noted that the increase in ROS production effected by HG was suppressed (Fig. 6A) .
It has previously been noted that NO produced by eNOS exerts anti-inflammatory effects on the vascular wall, and inhibits the migration and proliferation of vascular smooth muscle cells (25) . Thus, in the present study we detected the intracellular NO level in HUVECs. We noted that intracellular NO levels were decreased by HG, whereas UCP2 overexpression increased intracellular NO levels (Fig. 6B) .
Discussion
Therapeutic strategies to treat complications associated with DR previously consisted predominantly of controlling systemic vascular deregulation (26) (27) (28) (29) . Although laser photocoagulation and targeted treatments, such as locally administered corticosteroids, are currently available, their off-target effects underscore the need to explore novel therapeutic approaches (30, 31) . In the present study, we provide evidence that UCP2 plays a critical role in vascular cell apoptosis induced by HG in DR.
A previous study has shown that loss of retinal capillary endothelial and mural cells and focal BM thickening has been noted in streptozotocin-induced diabetic rats (32) . Similarly, in the present study we performed TUNEL assay on retinal sections to measure cell death in the UCP2-knockout mice, db/db mice and C57 mice. Notably, UCP2-knockout mice exhibited DR-like damage, similar to db/db mice. We noted an increase in TUNEL in the ganglion cell layer of UCP2-knockout mice and db/db mice compared to the wild-type mice. Furthermore, compared with non-diabetic mice, the BMT was also significantly increased in the UCP2-knockout mice and db/db mice. There was no significant difference between UCP2-knockout mice and db/db mice. These results suggest that UCP2 exerts a protective effect in the early stages of DR.
Endothelial apoptosis is an important early event in the pathogenesis of DR, and increased intracellular oxidative stress plays an important causative role in the pathogenesis of endothelial apoptosis (33) (34) (35) (36) . Moreover, caspase-3 activation is a crucial step in the process of apoptosis. Activation of caspase-3 is essential for cell execution and occurs immediately prior to the development of morphological changes consistent with apoptosis (37) . Hence, a cell with activated caspase-3 is considered destined to die. In agreement with previous research on other cell types (38) , in the present study, we noted that suppression of UCP2 expression using UCP2-specific siRNA exaggerated caspase-3 activation and apoptosis induced by HG. Conversely, overexpression of UCP2 inhibited HG-induced endothelial apoptosis and caspase-3 activation. In addition, UCP2 overexpression decreased ROS generation, PTP opening, and cytochrome c release induced by HG. These data demonstrate that endogenous UCP2 expression is important for preventing apoptosis in HUVECs.
The endothelium acts not only as a barrier, but also as a regulator of vascular tone and smooth muscle cell growth, migration, and proliferation. Vascular tone is modulated through the release of relaxing and contracting substrates. Of these, NO is physiologically the most important regulator of vascular tone. Although a previous study demonstrated that the vascular benefit of UCP2 was due to increased NO bioavailability after the inhibition of ROS production in HG-treated primary mouse aortic endothelial cells (39) , in the present study we showed that HG significantly increased intracellular ROS production and decreased intracellular NO levels in HUVECs. UCP2 overexpression reversed these effects. Thus, we suggest that UCP2 reduces ROS production and increases NO levels. 
